Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.74 |
| ▸ | MEN1 | O00255 | 7/20 | 0.74 |
| ▸ | NPC1 | O15118 | 3/20 | 0.66 |
| ▸ | RAB9A | P51151 | 2/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.66 |
| ▸ | MITF | O75030 | 1/20 | 0.66 |
| ▸ | TGM2 | P21980 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | NAMPT | P43490 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | MYOC | Q99972 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17289271 | 0.94 | KMT2A (0.67) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL4690573 | 0.89 | MEN1 (0.79) | KMT2AMEN1NPC1RAB9APOLB | |
| Hydrochloric Acid SCHEMBL11555611 | 0.89 | KMT2A (0.61) | KMT2AMEN1NPC1RAB9APOLB | |
| Nitrobenzene SCHEMBL28122132 | 0.88 | MEN1 (0.62) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL1177730 | 0.85 | MEN1 (1.00) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL6302157 | 0.85 | MEN1 (1.00) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL3189929 | 0.84 | KMT2A (0.69) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL5817153 | 0.83 | KMT2A (0.74) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL21597887 | 0.83 | NAMPT (0.63) | KMT2AMEN1NPC1RAB9APOLB | |
| SCHEMBL11055960 | 0.82 | MEN1 (0.85) | KMT2AMEN1NPC1RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 551 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119931396-A | Water-based asphalt insect-damage-prevention anticorrosive paint and processing technology thereof | 安徽欣苗新材料科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| EP-3407916-B1 | PHOSPHONATE LINKERS AND THEIR USE TO FACILITATE CELLULAR RETENTION OF COMPOUNDS | MERCK SHARP & DOHME LLC (US) | 2023-12-20 | — | — | EP | claimed |
| CN-106771137-B | Detect enzyme linked immunological kit and its application of Nicarbazin | 浙江省食品药品检验研究院 | 2018-10-02 | — | — | CN | claimed |
| CN-106771137-A | Detect enzyme linked immunological kit and its application of Nicarbazin | 浙江省食品药品检验研究院 | 2017-05-31 | — | — | CN | claimed |
| US-9448173-B2 | Dye-conjugated dendrimers | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2016-09-20 | — | — | US | claimed |
| EP-1718667-B1 | HETEROCYCLIC SELF-IMMOLATIVE LINKERS AND CONJUGATES | GENENTECH INC (US) | 2013-01-09 | — | — | EP | claimed |
| US-20120256102-A1 | Dye-conjugated dendrimers | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-10-11 | — | — | US | claimed |
| WO-2006138589-A2 | OPIOID RECEPTOR LIGANDS | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2006-12-28 | — | — | WO | claimed |
| US-20040110768-A1 | Bombesin receptor antagonists | WARNER-LAMBERT COMPANY LLC | 2004-06-10 | — | — | US | claimed |
| US-5378836-A | Antibody inhibitors, fungicides; antiinflammatory and antitumor agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-01-03 | — | — | US | claimed |
| EP-0509795-A2 | Carbamates of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-10-21 | — | — | EP | claimed |
| US-5118678-A | Antibody inhibitors, antiinflammatory agents, fungicides, antitumor agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1992-06-02 | — | — | US | claimed |
| EP-4698275-A1 | PYRROLIDINONE UREA FPR2 AGONISTS | Bristol-Myers Squibb Company (US) | 2026-02-25 | — | — | EP | disclosed |
| EP-4698516-A1 | PYRROLIDINONE UREA FPR2 AGONISTS | Bristol-Myers Squibb Company (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20250296971-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-09-25 | — | — | US | disclosed |
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | disclosed |
| US-4170708-A | FROM AN AROMATIC NITRO COMPOUND, AN ALCOHOL, AND CARBON MONOXIDE | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1979-10-09 | — | — | US | disclosed |
| US-4138264-A | Silver halide emulsion containing two equivalent type coupler for use in photography | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1979-02-06 | — | — | US | disclosed |
| US-4134880-A | Process for producing an aromatic urethane from nitro compounds, hydroxyl compounds and carbon monoxide using metal-Lewis acid-ammonia catalyst systems | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1979-01-16 | — | — | US | disclosed |
| US-4061630-A | 7-Substituted-ureido-3-carbamoyloxymethyl cephalosporin antibiotics | ELI LILLY AND COMPANY (US) | 1977-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296971-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | GIPR, VIP, GRPR | KMT2A 3863/4885MEN1 1139/4885NPC1 4323/4885 |
| US-20040110768-A1 | Bombesin receptor antagonists | NPY1R, BDKRB1, NPY2R | KMT2A 3281/4885MEN1 343/4885NPC1 2690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.